Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Non-small Cell Lung Cancer Stage IIIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02572843
What this trial is testing

Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC Non-small Cell Lung Cancer
Swiss Cancer Institute 68
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Not applicableLooking for participantsNCT05732974
What this trial is testing

A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse

Who this might be right for
Non-small Cell Lung Cancer Stage IIIA
University Hospital, Toulouse 60
Not applicableWithdrawnNCT00499291
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Who this might be right for
Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)UnknownNCT01097317
What this trial is testing

First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityFatigueLung Cancer+1 more
Wales Cancer Trials Unit 52
Testing effectiveness (Phase 2)UnknownNCT00862004
What this trial is testing

Video-assisted Thoracoscopic Surgery for Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 30
Testing effectiveness (Phase 2)UnknownNCT00003284
What this trial is testing

High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer

Who this might be right for
Lung Cancer
Herbert Irving Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613
What this trial is testing

Cediranib in Combination With Olaparib in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more
National Cancer Institute (NCI) 122
Testing effectiveness (Phase 2)UnknownNCT01784549
What this trial is testing

Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease

Who this might be right for
Non Small Cell Lung Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 168
Large-scale testing (Phase 3)Study completedNCT00028938
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 1
Testing effectiveness (Phase 2)Ended earlyNCT00459121
What this trial is testing

Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 2
Testing effectiveness (Phase 2)WithdrawnNCT00547443
What this trial is testing

Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Texas Southwestern Medical Center
Large-scale testing (Phase 3)Active Not RecruitingNCT02595944
What this trial is testing

Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)

Who this might be right for
Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage II Lung Non-Small Cell Cancer AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 903
Testing effectiveness (Phase 2)UnknownNCT03903887
What this trial is testing

Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 20
Testing effectiveness (Phase 2)Ended earlyNCT00004093
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Northwestern University 36
Testing effectiveness (Phase 2)Study completedNCT00778167
What this trial is testing

Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00979212
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 71
Testing effectiveness (Phase 2)Looking for participantsNCT06492421
What this trial is testing

Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.

Who this might be right for
Lung CancerSurgeryNon-small Cell Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University 90
Early research (Phase 1)UnknownNCT00006212
What this trial is testing

Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Center for Molecular Medicine
Testing effectiveness (Phase 2)UnknownNCT01470716
What this trial is testing

Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations

Who this might be right for
NSCLC Stage IINSCLC, Stage IIIA
National Cancer Center, Korea 26
Next Page